{
  "scores": {
    "rubric_version": "v3.0-2025-10-14",
    "items": {
      "Title": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Design": {
        "score": 2,
        "evidence": "Patients were randomly assigned to the different treatments using computer-generated block randomization (block of six)."
      },
      "Participants": {
        "score": 2,
        "evidence": "Between May 2021 and December 2021, we treated 165 adult patients for trigger finger at an academic university hospital."
      },
      "Intervention": {
        "score": 2,
        "evidence": "Splinting involved the patient wearing a fixed metacarpophalangeal joint orthosis... Steroid injection was performed using 1 mL of 1% lidocaine without epinephrine and 1 mL of triamcinolone acetonide (10 mg/mL)."
      },
      "Objective": {
        "score": 1,
        "evidence": "Are there differences in pain reduction and functional improvement in adults with trigger finger treated with splinting alone, steroid injection alone, and a combination of splinting and steroid injection at 6, 12, and 52 weeks after the intervention?"
      },
      "Method_Outcome": {
        "score": 2,
        "evidence": "Primary outcomes evaluated were VAS pain reduction and improvement in Michigan Hand Outcomes Questionnaire (MHQ) scores at 6, 12, and 52 weeks after the intervention."
      },
      "Randomisation_Allocation": {
        "score": 2,
        "evidence": "Patients were randomly assigned to the different treatments using computer-generated block randomization (block of six). Sequentially numbered, opaque, sealed envelopes were used in the allocation concealment process."
      },
      "Blinding": {
        "score": 2,
        "evidence": "Both the allocator and the outcome assessor were blinded."
      },
      "Number_Randomised": {
        "score": 2,
        "evidence": "After screening, 120 patients were randomized to receive either splinting (n = 43), steroid injection (n = 40), or splinting plus steroid injection (n = 37)."
      },
      "Number_Analysed": {
        "score": 2,
        "evidence": "An intention-to-treat analysis was performed with all 120 patients, and a per-protocol analysis was conducted with 86 patients."
      },
      "Result_Outcome": {
        "score": 2,
        "evidence": "There were no clinically important differences in VAS pain scores among the three treatment groups at any timepoint, in either the intention-to-treat or the per-protocol analyses."
      },
      "Harms": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Trial_Registration": {
        "score": 0,
        "evidence": "Not reported"
      },
      "Funding": {
        "score": 0,
        "evidence": "Not reported"
      }
    },
    "total_score": 19,
    "max_score": 25
  },
  "model": "gpt-4o"
}